Published in J Cereb Blood Flow Metab on January 14, 2009
Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab (2009) 2.85
Expression profile of MicroRNAs in young stroke patients. PLoS One (2009) 2.23
MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J Cereb Blood Flow Metab (2010) 1.92
miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis (2010) 1.89
miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion (2011) 1.85
miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol Dis (2011) 1.61
Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J Cereb Blood Flow Metab (2009) 1.52
MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics (2010) 1.48
An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS One (2012) 1.40
Novel functions for small RNA molecules. Curr Opin Mol Ther (2009) 1.39
Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci (2010) 1.38
MicroRNA profiling in subventricular zone after stroke: MiR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway. PLoS One (2011) 1.37
MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci (2012) 1.35
Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J Neurochem (2010) 1.30
Effects of gender on gene expression in the blood of ischemic stroke patients. J Cereb Blood Flow Metab (2011) 1.20
MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease. Cell Cycle (2009) 1.19
MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. J Biol Chem (2010) 1.19
MicroRNA miR-29c down-regulation leading to de-repression of its target DNA methyltransferase 3a promotes ischemic brain damage. PLoS One (2013) 1.19
The emerging roles of microRNAs in CNS injuries. Nat Rev Neurol (2013) 1.18
Effect of focal ischemia on long noncoding RNAs. Stroke (2012) 1.16
Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury. PLoS One (2011) 1.14
Inhibition of microRNA-181 reduces forebrain ischemia-induced neuronal loss. J Cereb Blood Flow Metab (2013) 1.11
microRNAs: innovative targets for cerebral ischemia and stroke. Curr Drug Targets (2013) 1.10
MicroRNA in central nervous system trauma and degenerative disorders. Physiol Genomics (2011) 1.10
Molecular mechanisms of neonatal brain injury. Neurol Res Int (2012) 1.07
Altered expression of PIWI RNA in the rat brain after transient focal ischemia. Stroke (2011) 1.07
MicroRNAs in CNS injury: potential roles and therapeutic implications. Bioessays (2011) 1.05
Astrocyte-enriched miR-29a targets PUMA and reduces neuronal vulnerability to forebrain ischemia. Glia (2013) 1.04
Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. J Cereb Blood Flow Metab (2011) 1.01
Ischemic preconditioning alters the epigenetic profile of the brain from ischemic intolerance to ischemic tolerance. Neurotherapeutics (2013) 1.01
Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke. Mol Neurobiol (2013) 1.00
MicroRNA dysregulation in the spinal cord following traumatic injury. PLoS One (2012) 0.98
The emerging role of epigenetics in stroke: II. RNA regulatory circuitry. Arch Neurol (2010) 0.98
microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. PLoS One (2014) 0.96
Blood microRNAs in low or no risk ischemic stroke patients. Int J Mol Sci (2013) 0.95
Increased cerebral protein ISGylation after focal ischemia is neuroprotective. J Cereb Blood Flow Metab (2011) 0.95
Increased binding of stroke-induced long non-coding RNAs to the transcriptional corepressors Sin3A and coREST. ASN Neuro (2013) 0.95
MicroRNAs in ischemia-reperfusion injury. Am J Cardiovasc Dis (2012) 0.94
An updated role of microRNA-124 in central nervous system disorders: a review. Front Cell Neurosci (2015) 0.94
Neuroprotection by astrocytes in brain ischemia: importance of microRNAs. Neurosci Lett (2013) 0.94
Circulating microRNAs as biomarkers of acute stroke. Int J Mol Sci (2014) 0.92
The therapeutic potential of microRNAs in nervous system damage, degeneration, and repair. Neuromolecular Med (2009) 0.92
MicroRNA dysregulation in spinal cord injury: causes, consequences and therapeutics. Front Cell Neurosci (2014) 0.91
miR-21 in ischemia/reperfusion injury: a double-edged sword? Physiol Genomics (2014) 0.91
The interplay of microRNA and neuronal activity in health and disease. Front Cell Neurosci (2013) 0.90
Tolerance to ischemia - an increasingly complex biology. Transl Stroke Res (2013) 0.89
Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model. Clin Sci (Lond) (2014) 0.89
The transcriptome of cerebral ischemia. Brain Res Bull (2012) 0.89
Angiogenesis-regulating microRNAs and Ischemic Stroke. Curr Vasc Pharmacol (2015) 0.89
All's well that transcribes well: non-coding RNAs and post-stroke brain damage. Neurochem Int (2013) 0.88
MicroRNAs mediating CNS inflammation: Small regulators with powerful potential. Brain Behav Immun (2015) 0.87
Integrating miRNA and mRNA expression profiles in response to heat stress-induced injury in rat small intestine. Funct Integr Genomics (2010) 0.87
microRNAs Involved in Regulating Spontaneous Recovery in Embolic Stroke Model. PLoS One (2013) 0.86
Role of microRNAs in stroke and poststroke depression. ScientificWorldJournal (2013) 0.86
The MicroRNAs and Stroke: No Need to be Coded to be Counted. Transl Stroke Res (2010) 0.85
Extracellular RNAs: development as biomarkers of human disease. J Extracell Vesicles (2015) 0.85
miRNAs-19b, -29b-2* and -339-5p show an early and sustained up-regulation in ischemic models of stroke. PLoS One (2013) 0.85
MicroRNA profiling in ischemic injury of the gracilis muscle in rats. BMC Musculoskelet Disord (2010) 0.85
MiR-146a regulates SOD2 expression in H2O2 stimulated PC12 cells. PLoS One (2013) 0.85
Long Noncoding RNA FosDT Promotes Ischemic Brain Injury by Interacting with REST-Associated Chromatin-Modifying Proteins. J Neurosci (2015) 0.85
Neuroprotection of microRNA in neurological disorders (Review). Biomed Rep (2014) 0.84
MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene. PLoS One (2013) 0.83
Identification of circulating microRNAs as potential biomarkers for detecting acute ischemic stroke. Cell Mol Neurobiol (2014) 0.83
Regulation of microRNAs miR-30a and miR-143 in cerebral vasculature after experimental subarachnoid hemorrhage in rats. BMC Genomics (2015) 0.83
Epigenetic mechanisms of neuroplasticity and the implications for stroke recovery. Exp Neurol (2014) 0.83
MicroRNA-103-1 selectively downregulates brain NCX1 and its inhibition by anti-miRNA ameliorates stroke damage and neurological deficits. Mol Ther (2014) 0.83
Non-Coding RNAs in Stroke and Neuroprotection. Front Neurol (2015) 0.82
tRNA-Derived Small Non-Coding RNAs in Response to Ischemia Inhibit Angiogenesis. Sci Rep (2016) 0.82
The use of microRNAs to modulate redox and immune response to stroke. Antioxid Redox Signal (2015) 0.81
Increase of circulating miR-223 and insulin-like growth factor-1 is associated with the pathogenesis of acute ischemic stroke in patients. BMC Neurol (2014) 0.81
Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke. Horm Behav (2012) 0.81
Repetitive transcranial magnetic stimulation promotes neural stem cell proliferation via the regulation of MiR-25 in a rat model of focal cerebral ischemia. PLoS One (2014) 0.81
Stroke-induced microRNAs: The potential therapeutic role for stroke. Exp Ther Med (2012) 0.81
Expression profiles of microRNAs after focal cerebral ischemia/reperfusion injury in rats. Neural Regen Res (2012) 0.81
MicroRNA-29b is a therapeutic target in cerebral ischemia associated with aquaporin 4. J Cereb Blood Flow Metab (2015) 0.80
MicroRNAs in Cerebral Ischemia. Stroke Res Treat (2013) 0.80
Mutual induction of transcription factor PPARγ and microRNAs miR-145 and miR-329. J Neurochem (2015) 0.80
Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage. J Neurosci (2016) 0.80
Epigenetics: an expanding new piece of the stroke puzzle. Transl Stroke Res (2011) 0.79
Blood microRNAs as potential diagnostic and prognostic markers in cerebral ischemic injury. Neural Regen Res (2016) 0.79
MicroRNAs: a novel promising therapeutic target for cerebral ischemia/reperfusion injury? Neural Regen Res (2015) 0.78
Circulating microRNA 132-3p and 324-3p Profiles in Patients after Acute Aneurysmal Subarachnoid Hemorrhage. PLoS One (2015) 0.78
Let-7a gene knockdown protects against cerebral ischemia/reperfusion injury. Neural Regen Res (2016) 0.78
Emerging molecular targets for brain repair after stroke. Stroke Res Treat (2013) 0.78
MicroRNA-378 Alleviates Cerebral Ischemic Injury by Negatively Regulating Apoptosis Executioner Caspase-3. Int J Mol Sci (2016) 0.78
Non-Coding RNAs as Potential Neuroprotectants against Ischemic Brain Injury. Brain Sci (2013) 0.77
Resveratrol preconditioning induces cerebral ischemic tolerance but has minimal effect on cerebral microRNA profiles. J Cereb Blood Flow Metab (2016) 0.77
MicroRNAs participate in the murine oligodendroglial response to perinatal hypoxia-ischemia. Pediatr Res (2014) 0.77
MicroRNA-146a Promotes Oligodendrogenesis in Stroke. Mol Neurobiol (2016) 0.77
Non-coding RNAs and neuroprotection after acute CNS injuries. Neurochem Int (2017) 0.76
A New Gene Therapy Approach for Cardiovascular Disease by Non-coding RNAs Acting in the Nucleus. Mol Ther Nucleic Acids (2014) 0.76
Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells. Immunology (2014) 0.76
Long non-coding RNA C2dat1 regulates CaMKIIδ expression to promote neuronal survival through the NF-κB signaling pathway following cerebral ischemia. Cell Death Dis (2016) 0.76
An Antagomir to MicroRNA-106b-5p Ameliorates Cerebral Ischemia and Reperfusion Injury in Rats Via Inhibiting Apoptosis and Oxidative Stress. Mol Neurobiol (2016) 0.76
Identifying the role of microRNAs in spinal cord injury. Neurol Sci (2014) 0.76
Protective effect of oxysophoridine on cerebral ischemia/reperfusion injury in mice. Neural Regen Res (2013) 0.76
Changes in Rat Brain MicroRNA Expression Profiles Following Sevoflurane and Propofol Anesthesia. Chin Med J (Engl) (2015) 0.76
Life or death? A physiogenomic approach to understand individual variation in responses to hemorrhagic shock. Curr Genomics (2011) 0.75
Neuroprotection induced by post-conditioning following ischemia/reperfusion in mice is associated with altered microRNA expression. Mol Med Rep (2016) 0.75
Attenuated neuroprotective effect of riboflavin under UV-B irradiation via miR-203/c-Jun signaling pathway in vivo and in vitro. J Biomed Sci (2014) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
The functions of animal microRNAs. Nature (2004) 64.85
Prediction of mammalian microRNA targets. Cell (2003) 53.70
The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 35.49
Human MicroRNA targets. PLoS Biol (2004) 34.51
Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell (2001) 25.86
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58
A distinct small RNA pathway silences selfish genetic elements in the germline. Science (2006) 11.63
A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell (2005) 9.22
Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell (2005) 9.01
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res (2007) 7.98
Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol (2004) 7.33
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci U S A (2001) 7.12
Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells (2005) 6.72
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci U S A (2005) 5.35
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A (2008) 5.24
miR-148 targets human DNMT3b protein coding region. RNA (2008) 4.56
MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke (2008) 3.16
Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet (2008) 2.33
Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab (2006) 2.20
Retracted Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochem Biophys Res Commun (2008) 1.91
MicroRNA: past and present. Front Biosci (2007) 1.79
Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. J Cereb Blood Flow Metab (2006) 1.67
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem (2007) 1.61
JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J Neurochem (2006) 1.49
Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem (2004) 1.46
MicroRNA involvement in brain tumors: from bench to bedside. Brain Pathol (2008) 1.40
Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics (2006) 1.39
Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia. J Neurochem (2006) 1.35
Genomics of the periinfarction cortex after focal cerebral ischemia. J Cereb Blood Flow Metab (2003) 1.32
Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J Neurochem (2002) 1.30
Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression. Neurobiol Dis (2005) 1.19
Everything you wanted to know about small RNA but were afraid to ask. Lab Invest (2008) 1.14
Neuroprotection by endogenous and exogenous PACAP following stroke. Regul Pept (2006) 1.12
Small RNAs in human brain development and disorders. Biochemistry (Mosc) (2005) 1.07
Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J Neurochem (2008) 1.07
Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia. J Cereb Blood Flow Metab (2000) 1.06
Genomics of brain and blood: progress and pitfalls. Epilepsia (2006) 0.91
Microarray analysis of gene expression on herbal glycoside recipes improving deficient ability of spatial learning memory in ischemic mice. J Neurochem (2004) 0.87
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci (2008) 1.88
Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res (2011) 1.84
RNAa is conserved in mammalian cells. PLoS One (2010) 1.81
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res (2006) 1.73
Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. J Cereb Blood Flow Metab (2006) 1.67
Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res (2012) 1.65
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem (2007) 1.61
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res (2010) 1.54
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget (2010) 1.53
Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J Pharmacol Exp Ther (2006) 1.52
JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J Neurochem (2006) 1.49
Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J Neurosci Methods (2004) 1.47
Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem (2004) 1.46
The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol (2006) 1.43
PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res (2008) 1.41
Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther (2008) 1.39
Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA (2011) 1.36
Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia. J Neurochem (2006) 1.35
Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem Int (2007) 1.35
Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J Neurochem (2010) 1.30
Insulin-like growth factor-1 is an endogenous mediator of focal ischemia-induced neural progenitor proliferation. Eur J Neurosci (2006) 1.26
Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF. J Neurochem (2003) 1.25
Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin Cancer Res (2005) 1.25
MicroRNA miR-29c down-regulation leading to de-repression of its target DNA methyltransferase 3a promotes ischemic brain damage. PLoS One (2013) 1.19
Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res (2005) 1.18
Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS Genet (2013) 1.18
Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer (2006) 1.17
Effect of focal ischemia on long noncoding RNAs. Stroke (2012) 1.16
Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate (2010) 1.15
Prevention of inflammation is a mechanism of preconditioning-induced neuroprotection against focal cerebral ischemia. Neurochem Int (2006) 1.15
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res (2005) 1.14
Mechanism of insulin-like growth factor I-mediated proliferation of adult neural progenitor cells: role of Akt. Eur J Neurosci (2007) 1.11
A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun (2007) 1.09
Defining features and exploring chemical modifications to manipulate RNAa activity. Curr Pharm Biotechnol (2010) 1.09
Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res (2005) 1.09
Altered expression of PIWI RNA in the rat brain after transient focal ischemia. Stroke (2011) 1.07
Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J Neurochem (2008) 1.07
Galectin-3 mediates post-ischemic tissue remodeling. Brain Res (2009) 1.07
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer (2005) 1.06
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res (2004) 1.05
Repairing brain after stroke: a review on post-ischemic neurogenesis. Neurochem Int (2007) 1.05
A review of carotid atherosclerosis and vascular cognitive decline: a new understanding of the keys to symptomology. Neurosurgery (2010) 1.04
Potential biomarkers for the diagnosis of stroke. Expert Rev Cardiovasc Ther (2009) 1.03
Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions. J Neurosurg (2007) 1.01
CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer (2005) 1.00
Increased angiogenesis and angiogenic gene expression in carotid artery plaques from symptomatic stroke patients. Neurosurgery (2006) 1.00
Impaired neurogenesis in adult type-2 diabetic rats. Brain Res (2008) 0.98
Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res (2006) 0.96
B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury. Spine (Phila Pa 1976) (2006) 0.96
The potential of neural stem cells to repair stroke-induced brain damage. Acta Neuropathol (2009) 0.96
EGF and FGF-2 infusion increases post-ischemic neural progenitor cell proliferation in the adult rat brain. Neurosurgery (2005) 0.96
Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. Prostate (2013) 0.95
Increased binding of stroke-induced long non-coding RNAs to the transcriptional corepressors Sin3A and coREST. ASN Neuro (2013) 0.95
Increased cerebral protein ISGylation after focal ischemia is neuroprotective. J Cereb Blood Flow Metab (2011) 0.95
Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia. Neurochem Int (2009) 0.94
Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells. Nucleic Acid Ther (2012) 0.94
Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol Carcinog (2007) 0.94
Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J (2012) 0.93
Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia. J Neurochem (2011) 0.93
miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence. J Cell Physiol (2014) 0.93
Preconditioning-induced ischemic tolerance stimulates growth factor expression and neurogenesis in adult rat hippocampus. Neurochem Int (2005) 0.93
Comparison of open surgery versus retroperitoneoscopic approach to chyluria. J Urol (2003) 0.92
microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models. PLoS One (2013) 0.92
Changes in spinal cord injury-induced gene expression in rat are strain-dependent. Spine J (2006) 0.91
Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates. Differentiation (2008) 0.91
Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Mol Ther Nucleic Acids (2012) 0.91
Retroperitoneal laparoscopic nephron-sparing surgery for renal tumors: report of 32 cases. Urology (2005) 0.89
Ideal suture diameter is critical for consistent middle cerebral artery occlusion in mice. Neurosurgery (2005) 0.89
Transient focal cerebral ischemia-induced neurogenesis in the dentate gyrus of the adult mouse. J Neurosurg (2004) 0.88
Molecular evidence of repair and plasticity following spinal cord injury. Neuroreport (2004) 0.88
An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment. J Vis Exp (2012) 0.87
miRNA goes nuclear. RNA Biol (2012) 0.87
Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer. Urol Int (2008) 0.86
Adult interleukin-6 knockout mice show compromised neurogenesis. Neuroreport (2011) 0.85
CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinog (2002) 0.84
Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling. Brain Res (2012) 0.84
Comparison of retroperitoneoscopic nephrectomy versus open approaches to nonfunctioning tuberculous kidneys: a report of 44 cases. J Urol (2005) 0.84
Retroperitoneoscopic subcapsular nephrectomy for infective nonfunctioning kidney with dense perinephric adhesions. BJU Int (2004) 0.84
Small RNA and its application in andrology and urology. Transl Androl Urol (2012) 0.84
MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene. PLoS One (2013) 0.83
MicroRNA regulation of neuron-like differentiation of adipose tissue-derived stem cells. Differentiation (2009) 0.82
Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder. J Urol (2003) 0.81
Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective. Int J Urol (2012) 0.80
Persistent migration of neuroblasts from the subventricular zone to the injured striatum mediated by osteopontin following intracerebral hemorrhage. J Neurochem (2009) 0.80
Lack of response to epidermal growth factor in adult neural progenitor cells. Neuroreport (2005) 0.80
Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. Stem Cells Dev (2014) 0.80
saRNA guided iNOS up-regulation improves erectile function of diabetic rats. J Urol (2013) 0.79
Effect of sex and age interactions on functional outcome after stroke. CNS Neurosci Ther (2014) 0.78
RNAa in action: from the exception to the norm. RNA Biol (2014) 0.78
Apoptosis and gene expression after TBI. Leg Med (Tokyo) (2009) 0.78
Kidney gene database: a curated and integrated database of genes involved in kidney disease. J Urol (2004) 0.78
Transforming growth factor-beta(s) and their receptors in aging rat prostate. Biochem Biophys Res Commun (2002) 0.75
Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches. Metab Brain Dis (2015) 0.75